Is progesterone a candidate neuroprotective factor for treatment following ischemic stroke?

Neuroscientist

Volumn 15, Issue 4, 2009, Pages 324-332

  Gibson, Claire L ^a   Coomber, Ben ^a   Rathbone, James ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Focal ischemia; Neuroprotection; Progesterone; Steroids; Stroke

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; ESTROGEN; GESTAGEN; PREGNENOLONE; PROGESTERONE;

APOPTOSIS; BRAIN ISCHEMIA; BREAST CANCER; CELL LOSS; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HORMONE SUBSTITUTION; HUMAN; MALE; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEX DIFFERENCE; STROKE; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL SURVIVAL; CLINICAL TRIALS AS TOPIC; HUMANS; NERVE DEGENERATION; NEURONS; NEUROPROTECTIVE AGENTS; PROGESTERONE; STROKE;

EID: 68949124785     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858409333069     Document Type: Review

References (86)

1. Aggarwal R., Medhi B., Pathak A., Dhawan V., Chakrabarti A. 2008. Neuroprotective effect of progesterone on acute phase changes induced by partial global cerebral ischaemia in mice. J Pharm Pharmacol 60: 731-7.
2. Alkayed NJ, Harukani I., Kimes AS, London ED, Traystman RJ, Hurn PD 1998. Gender-linked brain injury in experimental stroke. Stroke 29: 159-66.
3. Alkayed NJ, Traystman RJ, Hurn PD, Miller VM 2000. Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 31: 161-8.
4. Belelli D., Lambert JJ 2005. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat Rev Neurosci 6: 565-75.
5. Bingham D., Macrae IM, Carswell HV 2005. Detrimental effects of 17beta-oestradiol after permanent middle cerebral artery occlusion. J Cereb Blood Flow Metab 25: 414-20.
6. Brann DW, Zamorano PL, De Sevilla L., Mahesh VB 2005. Expression of glutamate receptor subunits in the hypothalamus of the female rat during the afternoon of the proestrous luteinizing hormone surge and effects of antiprogestin treatment and aging. Neuroendocrinology 81: 120-8.
7. Brinton RD, Thompson RF, Foy MR, Baudry M., Wang J., Finch CE, and others. 2008. Progesterone receptors: form and function in brain. Front Neuroendocrinol 29: 313-39.
8. Cai W., Zhu Y., Furuya K., Li Z., Sokabe M., Chen L. 2008. Two different molecular mechanisms underlying progesterone neuroprotection against ischemic brain damage. Neuropharmacology 55: 127-38.
9. Carswell HV, Bingham D., Wallace K., Nilsen M., Graham DI, Dominiczak AF, and others. 2004. Differential effects of 17beta-estradiol upon stroke damage in stroke prone and normotensive rats. J Cereb Blood Flow Metab 24: 298-304.
10. Cervantes M., González-Vidal MD, Ruelas R., Escobar A., Moralí G. 2002. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res 33: 6-14.
11. Chen J., Chopp M., Li Y. 1999. Neuroprotective effects of progesterone after transient middle cerebral artery occlusion in rat. J Neurol Sci 171: 24-30.
12. Choi YC, Lee JH, Hong KW, Lee KS 2004. 17 b-Estradiol prevents focal cerebral ischemic damage via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam Clin Pharmacol 18: 547-57.
13. Coughlan T., Gibson CL, Murphy SP 2005. Modulatory effects of progesterone on NOS-2 expression in vivo and in vitro. J Neurochem 93: 932-42.
14. Cutler SM, VanLandingham JW, Stein DG 2006 a. Tapered progesterone withdrawal promotes long-term recovery following brain trauma. Exp Neurol 200: 378-85.
15. Cutler SM, VanLandingham JW, Murphy AZ, Stein DG 2006 b. Slow-release and injected progesterone treatments enhance acute recovery after traumatic brain injury. Pharmacol Biochem Behav 84: 420-8.
16. Djebaili MS, Hoffman SW, Stein DG 2004. Allopregnanolone and progesterone decrease cell death and cognitive deficits after a contusion of the rat pre-frontal cortex. Neuroscience 123: 349-59.
17. Donnan GA, Fisher M., Macleod M., Davis SM 2008. Stroke. Lancet 371: 1612-23.
18. Gebel JM, Jauch EC, Brott TG, Khoury J., Sauerbeck L., Salisbury S., and others. 2002. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 33: 2636-41.
19. Ghoumari AM, Baulieu EE, Schumacher M. 2005. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135: 47-58.
20. Gibson CL, Constantin DC, Prior MJW, Bath PMW, Murphy SP 2005. Progesterone suppresses the inflammatory response and nitric oxide synthase-2 expression following cerebral ischemia. Exp Neurol 193: 522-30.
21. Gibson CL, Gray LJ, Bath PMW, Murphy SP 2008. Progesterone for the treatment of experimental brain injury: a systematic review. Brain 131: 318-28.
22. Gibson CL, Gray LJ, Murphy SP, Bath PMW. 2006. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 26: 1103-13.
23. Gibson CL, Murphy SP 2004. Progesterone enhances functional recovery following middle cerebral artery occlusion in male mice. J Cereb Blood Flow Metab 24: 805-13.
24. Ginsberg MD 2009. Current status of neuroprotection for cerebral ischaemia, synoptic overview. Stroke 40: S111-4.
25. Gonzalez SL, Labombarda F., Deniselle MC, Mougel A., Guennoun R., Schumacher M., and others. 2005. Progesterone neuroprotection in spinal cord trauma involves up-regulation of brain-derived neurotrophic factor in motoneurons. J Steroid Biochem Mol Biol 94: 143-9.
26. González-Vidal MD, Cervera-Gaviria M., Ruelas R., Escobar A., Moralí G., Cervantes M. 1998. Progesterone: protective effects on the cat hippocampal neuronal damage due to acute global cerebral ischemia. Arch Med Res 29: 117-24.
27. Green AR, Odergren T., Ashwood T. 2003. Animal models of stroke: do they have value for discovering neuroprotective agents ? Trends Pharmacol Sci 24: 402-8.
28. Guennoun R., Meffre D., Labombarda F., Gonzalez SL, Deniselle MC, Stein DG, and others. 2008. The membrane-associated progesterone-binding protein 25-Dx: expression, cellular localization and up-regulation after brain and spinal cord injuries. Brain Res Rev 57: 493-505.
29. Guo Q., Sayeed I., Baronne LM, Hoffman SW, Guennoun R., Stein DG 2006. Progesterone administration modulates AQP4 expression and edema after traumatic brain injury in male rats. Exp Neurol 198: 469-78.
30. Hattori K., Lee H., Hurn PD, Crain BJ, Traystman RJ, DeVries AC 2000. Cognitive deficits after focal cerebral ischemia in mice. Stroke 31: 1939-44.
31. He J., Evans CO, Hoffman SW, Oyesiku NM, Stein DG 2004. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol 189: 404-12.
32. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., and others; the HERS Research Group. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA 280: 605-11.
33. Hurn PD, Macrae IM 2000. Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 20: 631-52.
34. Hurn PD, Aardelt AA, Alkayed NJ, Crain BJ, Hu W., Kearney ML, and others. 2002. Estrogen and testosterone as neuroprotectants in stroke. In: Krieglstein J, editor. Pharmacology of cerebral ischemia 2002. Stuttgart: Medpharm Scientific Publishers. p 17-24.
35. Irwin RW, Yao J., Hamilton RT, Cadenas E., Brinton RD, Nilsen J. 2008. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 149: 3167-75.
36. Jiang N., Chopp M., Stein D., Feit H. 1996. Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats. Brain Res 735: 101-7.
37. Koenig HL, Schumacher M., Ferzaz B., Thi AN, Ressouches A., Guennoun R., and others. 1995. Progesterone synthesis and myelin formation by Schwann cells. Science 268: 1500-3.
38. Kumon Y., Kim SC, Tompkins P., Stevens A., Sakaki S., Loftus CM 2000. Neuroprotective effect of postischemic administration of progesterone in spontaneously hypertensive rats with focal cerebral ischemia. J Neurosurg 92: 848-52.
39. Lena C., Changeux JP 1993. Allosteric modulations of the nicotinic acetylcholine receptor. Trends Neurosci 16: 181-6.
40. Liu X., Zhang W., Alkayed NJ, Froehner SC, Adams ME, Amiry-Moghaddam M., and others. 2008. Lack of sex-linked differences in cerebral edema and aquaporin-4 expression after experimental stroke. J Cereb Blood Flow Metab 28: 1898-1906.
41. Lo EH, Dalkara T., Moskowitz MA 2003. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 4: 399-415.
42. Macleod MR, O'Collins T., Horky LL, Howells DW, Donnan GA 2005. Pooling of animal experimental data reveals influence of study design and publication bias. J Cereb Blood Flow Metab 25: 713-21.
43. Macrae IM, Carswell HV 2006. Oestrogen and stroke: the potential for harm as well as benefit. Biochem Soc Trans 34: 1362-5.
44. Mani SK 2006. Signaling mechanisms in progesterone-neurotransmitter interactions. Neuroscience 138: 773-81.
45. Manley GT, Fujimura M., Ma T., Noshita N., Filiz F., Bollen AW, and others. 2000. Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke. Nat Med 6: 159-63.
46. Maurice T., Gregoire C., Espallergues J. 2006. Neuro(active)steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav 84: 581-97.
47. Meffre D., Delespierre B., Gouezou M., Leclerc P., Vinson GP, Schumacher M, Stein and others. 2005. The membrane-associated progesterone-binding protein 25-Dx is expressed in brain regions involved in water homeostasis and is up-regulated after traumatic brain injury. J Neurochem 93: 1314-26.
48. Moralí G., Letechipía-Vallejo G., López-Loeza E., Montes P., Hernández-Morales L., Cervantes M. 2005. Post-ischemic administration of progesterone in rats exerts neuroprotective effects in the hippocampus. Neurosci Lett 382: 286-90.
49. Murphy SJ, Traystman RJ, Hurn PD 2000. Progesterone exacerbates striatal stroke injury in progesterone-deficient animals. Stroke 31: 1173-8.
50. Murphy SJ, Littleton-Kearney MT, Hurn PD 2002. Progesterone administration during reperfusion, but not preischemia alone, reduces injury in ovariectomised rats. J Cereb Blood Flow Metab 22: 367-88.
51. Murphy SJ, McCullough LD, Smith JM 2004. Stroke in the female: role of biological sex and estrogen. ILAR J 45: 147-59.
52. Niermann H., Amiry-Moghaddam M., Holthoff K., Witte OW, Ottersen OP 2001. A novel role of vasopressin in the brain: modulation of activity-dependent water flux in the neocortex. J Neurosci 21: 3045-51.
53. Nilsen J., Brinton RD 2002. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 143: 205-12.
54. Papadopoulos MC, Manley GT, Krishna S., Verkman AS 2004. Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. FASEB J 18: 1291-3.
55. Papadopoulos MC, Verkman AS 2007. Aquaporin-4 and brain edema. Pediatr Nephrol 22: 778-84.
56. Pettus EH, Wright DW, Stein DG, Hoffman SW 2005. Progesterone treatment inhibits the inflammatory agents that accompany traumatic brain injury. Brain Res 1049: 112-9.
57. Prencipe M., Ferretti C., Casini AR, Santini M., Giubilei F., Culasso F. 1997. Stroke, disability and dementia: results of a population survey. Stroke 28: 531-6.
58. Quick AM, Cipolla MJ 2005. Pregnancy-induced upregulation of aquaporin-4 protein in brain and its role in eclampsia. FASEB J 19: 170-5.
59. Rash JE, Yasumura T., Hudson CS, Agre P., Nielsen S. 1998. Direct immunogold labeling of aquaporin-4 in square arrays of astrocyte and ependymocyte plasma membranes in rat brain and spinal cord. Proc Natl Acad Sci USA 95: 11981-6.
60. Reglodi D., Tamas A., Lengvari I. 2003. Examination of sensorimotor performance following middle cerebral artery occlusion in rats. Brain Res Bull 59: 459-66.
61. Ribiero C., Hirt L., Bogousslavsky J., Regli L., Badaut J. 2006. Time course of aquaporin expression after transient focal cerebral ischemia in mice. J Neurosci Res 83: 1231-40.
62. Rogers DC, Campbell CA, Stretton JL, Mackay KB 1997. Correlation between motor impairment and infarct volume after permanent and transient middle cerebral artery occlusion in the rat. Stroke 28: 2060-6.
63. Roof RL, Duvdevani R., Heyburn JW, Stein DG 1996. Progesterone rapidly decreases brain edema: treatment delayed up to 24 hours is still effective. Exp Neurol 138: 246-51.
64. Sacco RL, Benjamin EJ, Broderick JP, Dyken M., Easton JD, Feinberg WM, and others. 1997. American heart association prevention conference IV: prevention and rehabilitation of stroke: risk factors. Stroke 28: 1507-17.
65. Savitz SI, Schabitz WR 2008. A critique of SAINT II: wishful thinking, dashed hopes, and the future of neuroprotection for acute stroke. Stroke 39: 1389-91.
66. Sayeed I., Guo Q., Hoffman SW, Stein DG 2006. Allopregnanolone, a progesterone metabolite, is more effective than progesterone in reducing cortical infarct volume after transient middle cerebral artery occlusion. Ann Emerg Med 47: 381-9.
67. Sayeed I., Wali B., Stein DG 2007. Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. Restor Neurol Neurosci 25: 151-9.
68. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. 1999. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med 5: 554-9.
69. Schumacher M., Guennoun R., Stein DG, De Nicola AF 2007. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 116: 77-106.
70. Simon JA, Hsia J., Cauley JA, Richards C., Harris F., Fong J., and others; the HERS Research Group. 2001. Postmenopausal hormone therapy and risk of stroke: the Heart and Estrogen-Progestin Replacement Study (HERS). Circulation 103: 638-42.
71. Singh M. 2006. Progesterone-induced neuroprotection. Endocrine 29: 271-4.
72. Stein DG, Wright DW, Kellermann AL 2008. Does progesterone have neuroprotective properties ? Ann Emerg Med 51: 164-72.
73. Stein DG 2005. The case for progesterone. Ann N Y Acad Sci 1052: 152-69.
74. Stroke Therapy Academic Industry Roundtable (STAIR). 1999. Recommendations for standards regarding pre-clinical neuroprotective and restorative drug development. Stroke 30: 2752-8.
75. Sydserff SG, Borellie AR, Green AR, Cross AJ 2002. Effects of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol 135: 103-12.
76. Toung TJ, Chen TY, Littleton-Kearney MT, Hurn PD, Murphy SJ 2004. Effects of combined estrogen and progesterone on brain infarction in reproductively senescent female rats. J Cereb Blood Flow Metab 24: 1160-6.
77. Toung TJ, Hurn PD, Traystman RJ, Sieber FE 2000. Estrogen decreases infarct size after temporary focal ischaemia in a genetic model of type I diabetes mellitus. Stroke 31: 2701-6.
78. Turgeon JL, McDonnell, Martin KA, Wise PM 2004. Hormone therapy: physiological complexity belies therapeutic simplicity. Science 304: 1269-73.
79. Turtzo LC, McCullough LD 2008. Sex differences in stroke. Cerebrovasc Dis 26: 462-74.
80. Valera S., Ballivet M., Bertrand D. 1992. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 89: 9949-53.
81. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Makuch R., Horwitz RJ 2001. A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 345: 1243-9.
82. Wassertheil-Smoller S., Hendrix SL, Limacher M., Heiss G., Kooperberg C., Baird A., and others; WHI Investigators. 2003. Effect of estrogen plus progestin on stroke in postmenopausal women-the Women's Health Initiative: a randomized trial. JAMA 289: 2673-4.
83. Wenger NK, Speroff L., Packard B. 1993. Cardiovascular health and disease in women. N Engl J Med 329: 247-56.
84. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M., Rosewell KL 2001. Estradiol is a neuroprotective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev 37: 313-9.
85. Wright DW, Kellerman AL, Hertzberg VS, Clark PL, Frankel M., Goldstein FC, and others. 2007. ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med 49: 391-402.
86. Xiao G., Wei J., Yan W., Wand W., Lu Z. 2008. Improved outcomes from the administration of progesterone to patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care 12: R61.